Studying the activity of matrix metalloproteinases and antibodies to DNA in patients with autoimmune thyroiditis

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. In autoimmune thyroiditis, in addition to impaired immunological tolerance, a significant role is played by biochemical markers such as matrix metalloproteinases and antibodies to deoxyribonucleic acid (DNA), which can contribute to the pathogenesis of the disease.

Aim. Studying the activity of metalloproteinases-3, -7 and the level of antibodies to DNA in patients with autoimmune thyroiditis.

Material and methods. In 2019–2021 a non-randomized study in the research laboratory at the Department of Biochemistry of the Azerbaijan Medical University, during which the blood serum of 170 patients with autoimmune thyroiditis, 64 (37.6%) men, average age 39.4±11.2 years and 106 (62.4%) women, average age 37.8±9.05 years, was conducted. Inclusion criteria: men and women aged 18 years and older with a primary diagnosis of “autoimmune thyroiditis” without concomitant allergic or other autoimmune diseases and severe somatic disorders. The control group consisted of 65 people (average age 38.7±10.8 years) without any thyroid disease or autoimmune pathology. Analysis of clinical and laboratory studies with determination of the level of thyroid-stimulating hormone, free thyroxine and free triiodothyronine made it possible to divide patients into two groups: the first group — 74 patients with a subclinical form of the disease; the second group — 96 patients with a manifest form of the disease. In all patients, the activity of metalloproteinases-3 and -7 in the blood serum was determined by enzyme-linked immunosorbent assay, and the content of antibodies to native and denatured DNA was determined by enzyme-linked immunosorbent assay. Intergroup comparisons on quantitative indicators were carried out using the nonparametric Mann–Whitney rank test, taking into account the difference in the distribution of the analyzed indicators from the normal one. Qualitative characteristics were assessed as percentages.

Results. The median activity of metalloproteinases-3 and -7 in the total group of patients was 56 (51.0; 59.0) and 4.6 (4.3; 5.2) ng/ml, respectively, which was significantly higher than the control values — 23.0 (16.0; 26.0) and 3.6 (3.4; 4.1) ng/ml, respectively (p=0.0001252 and p=0.00054). There were no statistically significant differences in the level of metalloproteinase-7 in patients with subclinical and manifest thyroiditis (p=0.097), while the median activity of metalloproteinase-3 in the manifest group was 59.0 (56.0; 65.0) ng/ml and it was higher than in patients of the subclinical group by 13.2%. The content of antibodies to native DNA in patients was 4.4 (2.3; 9.9) units/ml, which was statistically significantly higher compared to the control group — 2.6 (1.5; 3.6) units/ml (p <0.001), while no significant differences were found in the levels of antibodies to denatured DNA in patients compared to control values.

Conclusion. The worsening of the autoimmune process is accompanied by an increase in the activity of metalloproteinases and antinuclear antibodies.

Full Text

Restricted Access

About the authors

Rena R. Rahimova

Azerbaijan Medical University

Email: r.rahimova10@yahoo.com
ORCID iD: 0000-0001-6080-0622

Cand. Sci. (Biol.), Assistant, Depart. of Biochemistry

Azerbaijan, Baku, Azerbaijan

Gulnara S. Dashdamirova

Azerbaijan Medical University

Email: gulnara.dashdamirova@gmail.com
ORCID iD: 0000-0003-4051-3559

Cand. Sci. (Biol.), Assistant, Depart. of Biochemistry

Azerbaijan, Baku, Azerbaijan

Ilaha J. Shahverdiyeva

Azerbaijan Medical University

Author for correspondence.
Email: ilahashahverdiyeva@gmail.com
ORCID iD: 0000-0003-3368-1124

M.D., Cand. Sci. (Med.), Researcher, Scientific Research Laboratory, Depart. of Biochemistry

Azerbaijan, Baku, Azerbaijan

Ilhama A. Karimova

Azerbaijan Medical University

Email: ilhama.kerimova@bk.ru
ORCID iD: 0000-0002-0665-131X

M.D., Cand. Sci. (Med.), Assistant, Depart. of Biochemistry

Azerbaijan, Baku, Azerbaijan

References

  1. Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C, Churilov LP, Ferrari SM, Antonelli A. Hashimotos' thyroiditis: Epidemiology, pathogenesis, cli-nic and therapy. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101367. doi: 10.1016/j.beem.2019.101367.
  2. Rahimova R. Relationship between CTLA4, TNF-α and PTPN22 gene polymorphism and the serum levels of antithyroglobulin and antiperoxidase antibodies in autoimmune thyroiditis. AIMS Medical Science. 2023;10(1):14–23. doi: 10.3934/medsci.2023002.
  3. Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG. Metalloproteinases and their inhibitors: Potential for the development of new therapeutics. Cells. 2020;9(5):1313. doi: 10.3390/cells9051313.
  4. Elnady BM, Kamal NM, Shaker RHM, Soliman AF, Hasan WA, Alghamdi HA, Algethami MM, Jajah MB. Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases. Medicine (Baltimore). 2016;95(38):e4336. doi: 10.1097/MD.0000000000004336.
  5. Singh D, Srivastava SK, Chaudhuri TK, Upadhyay G. Multifaceted role of matrix metalloproteinases (MMPs). Front Mol Biosci. 2015;2:19. doi: 10.3389/fmolb.2015.00019.
  6. Ågren MS, Keller UAD. Matrix metalloproteinases: How much can they do? Int J Mol Sci. 2020;21:2678. doi: 10.3390/ijms21082678.
  7. Shadrina AS, Plieva YaZ, Kushlinskiy DN, Morozov AA, Filipenko ML, Chang VL, Kushlinskii NE. Classification, regulation of activity, and genetic polymorphism of matrix metalloproteinases in health and disease. Almanac of clinical medicine. 2017;45(4):266–279. (In Russ.) doi: 10.18786/2072-0505-2017-45-4-266-279.
  8. Djurić T, Zivkovic M. Overview of MMP biology and gene associations in human diseases. Role Matrix Met Hum Body Pathol. 2017;1:3. doi: 10.5772/intechopen.70265.
  9. Young D, Das N, Anowai A, Dufour A. Matrix metalloproteases as influencers of the cells' social media. Int J Mol Sci. 2019;20(16):3847. doi: 10.3390/ijms20163847.
  10. Islam MS, Mohanto NC, Karim MR, Aktar S, Hoque MM, Rahman A, Jahan M, Khatun R, Aziz A, Salam KA, Saud ZA, Hossain M, Rahman A, Mandal A, Haque A, Miyataka H, Himeno S, Hossain K. Elevated concentrations of serum matrix metalloproteinase-2 and -9 and their associations with circulating markers of cardiovascular diseases in chronic arsenic-exposed individuals. Environ Health. 2015;14:92. doi: 10.1186/s12940-015-0079-7.
  11. Nagasaki T, Nagata Y, Wakita Y, Yamada S, Goto H, Imanishi Y, Onoda N, Emoto M, Inaba M. Association of heterogeneity of the thyroid gland with matrix metalloproteinase-3 in rheumatoid arthritis patients with Hashimoto's thyroiditis. Minerva Endocrinol. 2018;43(4):398–405. doi: 10.23736/S0391-1977.18.02725-6.
  12. Rahimova RR. Autoimmune thyroiditis (review of literature). Russian Clinical Laboratory Diagnostics. 2022;67(5):286–291. (In Russ.) doi: 10.51620/0869-2084-2022-67-5-286-291.
  13. Nisihara R, Pigosso YG, Prado N, Utiyama SRR, De Carvalho GA, Skare TL. Rheumatic disease autoantibodies in patients with autoimmune thyroid diseases. Med Princ Pract. 2018;27(4):332–336. doi: 10.1159/000490569.
  14. Granito A, Muratori L, Tovoli F, Muratori P. Diagnostic role of anti-dsDNA antibodies: Do not forget autoimmune hepatitis. Nat Rev Rheumatol. 2021;17(4):244. doi: 10.1038/s41584-021-00573-7.
  15. Dedov II, Mel`nichenko GA. Endokrinologiya. Natsional`noe rukovodstvo. 2-e izd. (Endocrinology. National manual. 2nd ed.) M.: GEOTAR-Media; 2016. 1112 с. (In Russ.)
  16. Delitala AP, Scuteri A, Doria C. Thyroid hormone diseases and osteoporosis. J Clin Med. 2020;9(4):1034. doi: 10.3390/jcm9041034.
  17. Hajiyev A, Azizova G, Efendiyev A. The molecular mechanisms of secondary osteoporosis: A literature review. Bali Medical Journal. 2020;9(2):562–566. doi: 10.15562/bmj.v9i2.1755.
  18. Zdor VV, Markelova EV, Geltser BI. New players in altered tolerance to thyroid gland antigens: an immunopathogenesis concept of autoimmune thyroid disease (review). Medical immunology. 2016;18(3):209–220. (In Russ.) doi: 10.15789/1563-0625-2016-3-209-220.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Рис. 1. Распределение пациентов, включённых в исследование, в зависимости от уровней антител к нативной ДНК

Download (19KB)
3. Рис. 2. Распределение пациентов, включённых в исследование, в зависимости от уровней антител к денатурированной ДНК

Download (17KB)

© 2023 Eco-Vector





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies